It was demonstrated that GTPBP4 promoted hepatocellular carcinoma (HCC) growth and metastasis both in vivo and in vitro and promoted aerobic glycolysis by inducing dimeric pyruvate kinase M2 (PKM2) formation (29). Here, PKM is linked to hepatocellular carcinoma.